Look for:

Our offer for

INCYTE CORP


ISIN:
US45337C1027
WKN:
45337C102

2021/01/19 19:29:07
Price
92.46 USD
Difference 2.10% (1.90)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,423 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)92.42 USD (100)
Ask (Ask size)92.50 USD (100)
Open91.32 USD
High92.74 USD
Low90.82 USD
Close (prev. day)90.56 USD
VWAP91.696201 USD
Volume (pcs)340,100
Trading volume31,190,032.08
Number of trades6,464
Last size100

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: INCYTE CORPPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/01/19 19:29:07
Price
92.46 USD
Difference 2.10% (1.90)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,423 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)92.42 USD (100)
Ask (Ask size)92.50 USD (100)
Open91.32 USD
High92.74 USD
Low90.82 USD
Close (prev. day)90.56 USD
VWAP91.696201 USD
Volume (pcs)340,100
Trading volume31,190,032.08
Number of trades6,464
Last size100

Performance and Risk

6M1Y3Y
Perf (%)-13.13%+12.44%-3.73%
Perf (abs.)-13.69+10.02-3.51
Beta0.920.640.80
Volatility38.5941.9840.04
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)92.59 USD (991,684)
Ø price 30 days | Ø volume 30 days (pcs.)87.07 USD (1,047,400)
Ø price 100 days | Ø volume 100 days (pcs.)87.91 USD (1,126,185)
Ø price 250 days | Ø volume 250 days (pcs.)89.37 USD (1,465,342)
YTD High | date95.43 USD (2021/01/12)
YTD Low | date83.12 USD (2021/01/06)
52 Weeks High | date110.37 USD (2020/07/07)
52 Weeks Low | date62.48 USD (2020/03/23)

All listings for INCYTE CORP

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2021/01/1917:3275.38 EUR0.002
Tradegate2021/01/1918:5775.96 EUR0.038
Stuttgart2021/01/1915:0274.30 EUR0.004
Nasdaq2021/01/1919:2992.46 USD31.196,464
Munich2021/01/1908:0275.33 EUR0.001
London Stock Exchange2021/01/1217:3394.195 USD0.011
Frankfurt2021/01/1908:0674.91 EUR0.001
Duesseldorf2021/01/1919:0076.04 EUR0.0017
Berlin2021/01/1918:4275.78 EUR0.0015

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=130964&ID_TYPE_IMAGE_LOGO=2

Contact Details

INCYTE CORPORATION
Michael Booth
Augustine Cut-Off 1801 19803 Wilmington, DE
Telefon: +1-302-498-6700
Fax: -
E-mail: mbooth@incyte.com

PDF Downloads

Annual report: INCYTE CORPPDF Download

Company Profile

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.

Members of Management Board

Hervé HoppenotChairman of Board of Directors
Paul J. ClancyMember of Board of Directors
Paul A. Friedman, M.D.Member of Board of Directors
Katherine High, M.D.Member of Board of Directors
Julian C. BakerMember of Board of Directors
Jean-Jacques BienaiméMember of Board of Directors
Edmund P. Harrigan, M.D.Member of Board of Directors
Wendy DixonMember of Board of Directors
Jacqualyn A. FouseMember of Board of Directors
Hervé HoppenotChairman of Managing Board
Vijay Iyengar, M.D.Member of Executive Committee
Steven H. Stein, M.D.Member of Executive Committee
Paula J. SwainMember of Executive Committee
Michael MorrisseyMember of Executive Committee
Maria E. PasqualeMember of Executive Committee
Jonathan E. DickinsonMember of Executive Committee
Christiana StamoulisMember of Executive Committee
Barry P. FlannellyMember of Executive Committee
Wenqing YaoMember of Executive Committee
Lothar H. FinkeMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.